| Quality by design approach for formulation development: a case study of dispersible tablets NA Charoo, AAA Shamsher, AS Zidan, Z Rahman International journal of pharmaceutics 423 (2), 167-178, 2012 | 184 | 2012 |
| Characterization of 5-fluorouracil microspheres for colonic delivery Z Rahman, K Kohli, RK Khar, M Ali, NA Charoo, AAA Shamsher AAPS PharmSciTech 7, E113-E121, 2006 | 131 | 2006 |
| Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil NA Charoo, AAA Shamsher, K Kohli, K Pillai, Z Rahman Colloids and surfaces B: Biointerfaces 65 (2), 300-307, 2008 | 100 | 2008 |
| Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies NA Charoo, K Kohli, A Ali, A Anwer Drug development and industrial pharmacy 29 (2), 215-221, 2003 | 76 | 2003 |
| Pediatric drug development: formulation considerations AA Ali, NA Charoo, DB Abdallah Drug development and industrial pharmacy 40 (10), 1283-1299, 2014 | 74 | 2014 |
| Antihepatotoxic activity of ginger ethanol extract in rats U Bhandari, AA Shamsher, KK Pillai, MSY Khan Pharmaceutical biology 41 (1), 68-71, 2003 | 59 | 2003 |
| Quality risk management in pharmaceutical development NA Charoo, AA Ali Drug development and industrial pharmacy 39 (7), 947-960, 2013 | 56 | 2013 |
| In‐vivo evaluation in rats of colon‐specific microspheres containing 5‐fluorouracil Z Rahman, K Kohli, SQ Zhang, RK Khar, M Ali, NA Charoo, M Tauseef, ... Journal of Pharmacy and Pharmacology 60 (5), 615-623, 2008 | 39 | 2008 |
| Lesson learnt from recall of valsartan and other angiotensin II receptor blocker drugs containing NDMA and NDEA impurities NA Charoo, AA Ali, SK Buha, Z Rahman AAPS PharmSciTech 20, 1-6, 2019 | 38 | 2019 |
| Characterization of 5-fluorouracil microsphere for colonic delivery R Ziyaur, K Kanchan, RK Khar, A Mushir, NA Charoo, AA Shamsher AAPS Pharm Sci Tech 7 (2), E47, 2006 | 32 | 2006 |
| Biowaiver monograph for immediate-release solid oral dosage forms: bisoprolol fumarate NA Charoo, AAA Shamsher, LY Lian, B Abrahamsson, R Cristofoletti, ... Journal of pharmaceutical sciences 103 (2), 378-391, 2014 | 26 | 2014 |
| Transdermal delivery of flurbiprofen: permeation enhancement, design, pharmacokinetic, and pharmacodynamic studies in albino rats NA Charoo, A Anwer, K Kohli, KK Pillai, Z Rahman Pharmaceutical development and technology 10 (3), 343-351, 2005 | 26 | 2005 |
| Simple and sensitive high-performance liquid chromatographic method for determination of transdermally applied flurbiprofen in rat plasma and excised skin samples NA Charoo, AAA Shamsher, K Kohli, KK Pillai, Z Rahman Chromatographia 62, 493-497, 2005 | 16 | 2005 |
| Assessment of implementation of antibiotic stewardship program in surgical prophylaxis at a secondary care hospital in Ras Al Khaimah, United Arab Emirates HS Alshehhi, AA Ali, DS Jawhar, EM Aly, S Swamy, MA Fattah, ... Scientific Reports 11 (1), 1042, 2021 | 12 | 2021 |
| Drug utilization review of cephalosporins in a secondary care hospital in United Arab Emirates M Abou-Shaaban, AA Ali, PGM Rao, A Majid International Journal of Clinical Pharmacy 38, 1367-1371, 2016 | 12 | 2016 |
| Effect of transdermally delivered aspirin on blood coagulation parameters AA Shamsher, NA Charoo, K Kohli, K Pillai, Z Rahman Am J Biomed Sci 2 (2), 129-141, 2010 | 11 | 2010 |
| Establishment of a bioequivalence-indicating dissolution specification for candesartan cilexetil tablets using a convolution model HA Hassan, NA Charoo, AA Ali, SS Alkhatem Dissolution Technol 22, 36-43, 2015 | 9 | 2015 |
| Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations AA Shamsher, NA Charoo, Z Rahman, KK Pillai, K Kohli Pharmaceutical Development and Technology 19 (1), 21-30, 2014 | 8 | 2014 |
| Is the demonstration of bioequivalence for clavulanic acid required in amoxicillin–clavulanic acid orally administered immediate-release products? NA Charoo, Z Rahman, AA Ali Journal of Pharmacy and Pharmacology 70 (7), 883-892, 2018 | 5 | 2018 |
| PROGRAMME DESCRIPTION: Experiential training during COVID-19 pandemic: a virtual attachment experience from a college of pharmaceutical sciences in the United Arab Emirates SA Rabbani, T Wadhwa, SB Sridhar, J Shareef, AA Ali, PGM Rao Pharmacy Education 21, 51-55, 2021 | 3 | 2021 |
